Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease.
暂无分享,去创建一个
T. Ogihara | S. Kihara | T. Funahashi | Y. Matsuzawa | T. Katsuya | H. Rakugi | K. Kishida | H. Nishizawa | N. Maeda | N. Ouchi | M. Ohishi | K. Ishikawa | S. Sumitsuji | Y. Iwashima | M. Kumada | T. Kawamoto | H. Hiraoka | Y. Okamoto | Tadashi Nakamura | K. Ohashi | H. Nagaretani | S. Matsumoto
[1] M. Maffei,et al. Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.
[2] K. Clément,et al. Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. , 2002, Human molecular genetics.
[3] M. Pfeffer,et al. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. , 2000, Circulation.
[4] T Nakamura,et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. , 1999, Circulation.
[5] C. Dina,et al. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. , 2002, Diabetes.
[6] S. Kihara,et al. Genomic structure and mutations in adipose-specific gene, adiponectin , 2000, International Journal of Obesity.
[7] Jonathan Krakoff,et al. Adiponectin and development of type 2 diabetes in the Pima Indian population , 2002, The Lancet.
[8] M. Matsuda,et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30 , 2002, Nature Medicine.
[9] M. Stumvoll,et al. Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes. , 2002, Diabetes.
[10] D. Milewicz,et al. Genetics of cardiovascular disease. , 2000, Circulation.
[11] T. Ogihara,et al. T+31C Polymorphism of Angiotensinogen Gene and Essential Hypertension , 2001, Hypertension.
[12] R. Turner,et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.
[13] S. Kihara,et al. Adipocyte-Derived Plasma Protein Adiponectin Acts as a Platelet-Derived Growth Factor-BB–Binding Protein and Regulates Growth Factor–Induced Common Postreceptor Signal in Vascular Smooth Muscle Cell , 2002, Circulation.
[14] N. Sattar,et al. Plasma Leptin and the Risk of Cardiovascular Disease in the West of Scotland Coronary Prevention Study (WOSCOPS) , 2001, Circulation.
[15] P. Raskin,et al. Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.
[16] C. Dina,et al. A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27. , 2001, Human molecular genetics.
[17] T Nakamura,et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[18] S. Kihara,et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. , 2000, Blood.
[19] P. Scherer,et al. A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. , 2002, Diabetes.
[20] M. Matsuda,et al. Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome. , 2002, Diabetes.
[21] T. Funahashi,et al. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). , 1996, Biochemical and biophysical research communications.
[22] S. Yamashita,et al. Enhanced expression of PAI–1 in visceral fat: Possible contributor to vascular disease in obeisty , 1996, Nature Medicine.
[23] S. Kihara,et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. , 2002, Journal of the American Society of Nephrology : JASN.
[24] T Nakamura,et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.
[25] Philipp E. Scherer,et al. A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes (*) , 1995, The Journal of Biological Chemistry.
[26] J. Weber,et al. Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[27] B. Spiegelman,et al. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.
[28] M. Matsuda,et al. Role of Adiponectin in Preventing Vascular Stenosis , 2002, The Journal of Biological Chemistry.
[29] T. Ogihara,et al. Association of Hypoadiponectinemia With Impaired Vasoreactivity , 2003, Hypertension.
[30] Y. Terauchi,et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity , 2001, Nature Medicine.
[31] T Nakamura,et al. An Adipocyte-Derived Plasma Protein, Adiponectin, Adheres to Injured Vascular Walls , 2000, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[32] T. Funahashi,et al. Decreased plasma adiponectin concentration in patients with essential hypertension. , 2003, American journal of hypertension.
[33] B. Spiegelman,et al. AdipoQ Is a Novel Adipose-specific Gene Dysregulated in Obesity (*) , 1996, The Journal of Biological Chemistry.
[34] P. Scherer,et al. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action , 2001, Nature Medicine.